Guangdong Lifestrong Pharmacy Co., Ltd. Stock

Equities

301111

CNE1000054T7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-06-17 pm EDT 5-day change 1st Jan Change
14.69 CNY +0.89% Intraday chart for Guangdong Lifestrong Pharmacy Co., Ltd. +2.16% -40.19%
Sales 2022 283M 39.05M Sales 2023 292M 40.29M Capitalization 3.93B 542M
Net income 2022 33M 4.55M Net income 2023 33M 4.55M EV / Sales 2022 9.49 x
Net cash position 2022 451M 62.2M Net cash position 2023 331M 45.64M EV / Sales 2023 12.3 x
P/E ratio 2022
93.4 x
P/E ratio 2023
117 x
Employees 522
Yield 2022
0.51%
Yield 2023
0.41%
Free-Float 28.61%
More Fundamentals * Assessed data
Dynamic Chart
Guangdong Lifestrong Pharmacy Co., Ltd. Approves Cash Dividend for 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guangdong Lifestrong Pharmacy Approves Final Cash Dividend on A Shares for 2022, Effective 01 June 2023 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Certain A Shares of Guangdong Lifestrong Pharmacy Co., Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022. CI
Certain A Shares of Guangdong Lifestrong Pharmacy Co., Ltd. are subject to a Lock-Up Agreement Ending on 3-DEC-2022. CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guangdong Lifestrong Pharmacy to Free Up Nearly 2 Million Shares For Trading MT
Guangdong Lifestrong Pharmacy Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on May 26, 2022 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Approves Cash Dividend for 2021 CI
Guangdong Lifestrong Pharmacy Co., Ltd. Proposes Cash Dividend for 2021 CI
More news
1 day+0.89%
1 week+2.16%
Current month-7.73%
1 month-12.56%
3 months-23.65%
6 months-41.54%
Current year-40.19%
More quotes
1 week
14.30
Extreme 14.3
14.86
1 month
13.50
Extreme 13.5
16.91
Current year
11.20
Extreme 11.2
25.95
1 year
11.20
Extreme 11.2
33.47
3 years
11.20
Extreme 11.2
66.60
5 years
11.20
Extreme 11.2
66.60
10 years
11.20
Extreme 11.2
66.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 02-08-31
Director of Finance/CFO 49 02-09-30
Director/Board Member 35 14-12-31
Members of the board TitleAgeSince
Director/Board Member 61 19-05-31
Director/Board Member 55 19-05-31
Chief Executive Officer 63 02-08-31
More insiders
Date Price Change Volume
24-06-18 14.69 +0.89% 1,399,279
24-06-17 14.56 0.00% 1,522,492
24-06-14 14.56 -0.27% 1,786,179
24-06-13 14.6 -0.88% 1,805,108
24-06-12 14.73 +2.43% 2,162,600

End-of-day quote Shenzhen S.E., June 17, 2024

More quotes
Guangdong Lifestrong Pharmacy Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Chinese patent medicines. The Company is also engaged in the production and sales of masks. The Company's main products include XiaoyanLidan Tablets, Danshitong Capsules, CanqiJiangtang Tablets, Kumu Injection, Fuyanping Capsules, Guipi Liquid, Gujing Bushen Pills, Jianer Qingjie Liquid and other medicines. The Company's products application scope covers biliary tract, hypoglycemic, heat clearing and detoxification, gynecology, tonic, pediatrics, cough and asthma, cardio cerebrovascular, cold, urology, digestion, rheumatism and traumatology.
More about the company
  1. Stock Market
  2. Equities
  3. 301111 Stock